Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin versus ticagrelor in congestive heart failure patients
ACTRN12613000826741Phase 2Withdrawn
- Sponsor
- St Vincent's Hospital
- Start
- Jul 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of aspirin and ticagrelor in heart failure (HF) (2 arms), sponsored by St Vincent's Hospital. Primary endpoints: Change in NT-proBNP and Change in arterial pressure waveforms / pulsatile afterload. Planned start Jul 2013; status: withdrawn.
02
Drugs
aspirinticagrelor
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on ACTRN12613000826741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000826741.